Cost comparison of radical prostatectomy and transperineal brachytherapy for localized prostate cancer. Urology 2000; 55: 68–72.Ciezki J, Angermeier K, Ulchaker J, et al. : Cost comparison of radical prostatectomy and transperineal brachytherapy for localized prostate cancer . Urology 2000, 55 :68...
- 《Annals of Internal Medicine》 被引量: 439发表: 2006年 Outcomes of Tamoxifen Chemoprevention for Breast Cancer in Very High-Risk Women: A Cost-Effectiveness Analysis To estimate the effects on survival, quality-adjusted survival, and health care costs of using tamoxifen for primary prevention ...
Transcript:Michael Fabrizio, MD, FACS:There is one thing I think we should mention, it’s kind of the elephant in the room. There’s always someone in the room or multiple urologists in the room who start talking about cost of therapy. And it’s not just Provenge, which is, on averag...
Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017 Recent research on genomic profiling of pancreatic ductal adenocarcinoma (PDAC) has identified many potentially actionable alterations. However, the feasib... D Ding,AA Javed...
A study on the integrated Chinese-Western medical treatment of Prostate cancer.(Chinese Medicine)(Clinical report) The article reports on the study that evaluates the standard Western medical treatment combined with Chinese medical therapy to support the righteous and repress cancer. It found that the...
Androgens and androgen receptors (AR) play a pivotal role in expression of the male phenotype. Several diseases, such as androgen insensitivity syndrome (AIS) and prostate cancer, are associated with alterations in AR functions. Indeed, androgen blockade
Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis. BJU Int. 2013;111(3):437-450. doi:10.1111/j.1464-410X.2012.11597.x PubMedGoogle ScholarCrossref 31. Roth JA, Gulati R, Gore JL, Cooperberg MR, Etzioni R...
Treatment options for prostate cancer range from surgery and radiation to endocrine manipulation and chemotherapy. Choice of treatment is dependent on the stage of the disease and cost-benefit ratio, costs being assessed in both medical and economic terms. The evaluation of chemotherapy in prostatic ...
Economics and Outcomes Research, Brussels, Belgium OBJECTIVE: An HPV/cancer epidemiology model has been developed aiming to be succinct in structure and data input providing valid long-term HPV infection and cancer case predictions , a first step for estimating cost-effectiveness of new HPV vaccines...
He had prostate cancer. “Well, it’s an eye-opener, you know. I didn’t know if I had to buy a yard sale sign, you know,” he said. “It’s a shocking thing … It always happens to someone else.” After getting over the shock, Sneddon, a retired police chief, quickly ...